Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
Drug Name | OC-001 |
Trade Name | |
Synonyms | OC001|OC 001 |
Drug Descriptions |
OC-001 is a monoclonal agonist antibody that targets TNFRSF9 (4-1BB; CD137), which potentially results in activation of T-cells and antitumor activity (Ann Oncol 33 (2022): S884). |
DrugClasses | TNFRSF9 Antibody 32 |
CAS Registry Number | NA |
NCIT ID | NA |
Therapy Name | Drugs | Efficacy Evidence | Clinical Trials |
---|---|---|---|
OC-001 | OC-001 | 0 | 1 |
OC-001 + unspecified PD-1 antibody | OC-001 unspecified PD-1 antibody | 0 | 1 |
OC-001 + unspecified PD-L1 antibody | OC-001 unspecified PD-L1 antibody | 0 | 1 |